Erdheim-Chester disease medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 19: | Line 19: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Rare diseases]] | |||
[[Category:Immune system disorders]] | |||
[[Category:Skeletal disorders]] | |||
[[Category:Syndromes]] | |||
[[Category:Hematology]] | |||
Latest revision as of 14:10, 21 September 2012
|
Erdheim-Chester disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erdheim-Chester disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Erdheim-Chester disease medical therapy |
|
Risk calculators and risk factors for Erdheim-Chester disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Current treatment options include:
- High-dose Corticosteroid therapy
- Cyclosporine
- Interferon-α[1]
- Chemotherapy
- Radiation therapy
All current treatments have had varying degrees of success.
The vinca alkaloids and anthracyclines have been used most commonly in ECD treatment.[2]
References
- ↑ "Erdheim Chester Disease - M. D. Anderson Cancer Center". Retrieved 2007-08-26.
- ↑ Gupta, A. (2002). "Erdheim-Chester disease with prominent pericardial involvement". American Journal of Medical Science. 324: 96–100. Unknown parameter
|coauthors=ignored (help)